Shorts

0:58
Heat, plastic, and exposure: What patients should know
a day ago
by
Aleece Fosnight, MSPAS, PA-C, CSC-S, CSE, IF, MSCP, HAES

0:52
Vivian Wan, MD, on the value of mapping biopsies for CIS detection
3 days ago
by
Vivian Wan, MD

1:12
FDA testosterone label updates: 2 meaningful changes
4 days ago
by
Helen L. Bernie, DO, MPH

0:36
EV-302 response rates put surgical consolidation in context
7 days ago
by
Betty Wang, MD

0:52
Amy E. Krambeck, MD, outlines anatomic enucleation course
8 days ago
by
Amy E. Krambeck, MD

1:23
Daniel J. George, MD, on the significance of capivasertib for PTEN-deficient mHSPC
9 days ago
by
Daniel J. George, MD

1:43
What it takes to move the needle on urologic patient safety
10 days ago
by
Matthew Nielsen, MD, MS, FACS

0:42
Why patients choose Break Wave over URS
11 days ago
by
Ben H. Chew, MD, MSc

0:36
Jenny N. Guo, MD, on key BPH takeaways from AUA 2026
15 days ago
by
Jenny N. Guo, MD

0:44
Joy Maulik, CRNP, highlights LUGPA Advanced Practice Provider Forum
16 days ago
by
Joy Maulik, CRNP

1:02
The UroOnc Minute: Patient selection for MDT in the PSMA-PET era
17 days ago
by
Adam B. Weiner, MD(+1 more)

0:55
Archan Khandekar, MD, on the future for AI in urology
18 days ago
by
Archan Khandekar, MD

0:45
Praful Ravi, MB, BChir, MRCP, on residual disease detection using PSMA-PET
21 days ago
by
Praful Ravi, MB, BChir, MRCP

0:28
What BULLSEYE's PFS data should—and shouldn't—mean
22 days ago
by
James Nagarajah, MD

0:28
Why Break Wave Lithotripsy is a game changer for stone care
23 days ago
by
Ben H. Chew, MD, MSc

0:40
Aleece Fosnight, MSPAS, PA-C, on what to tell patients about microplastics and bladder health
24 days ago
by
Aleece Fosnight, MSPAS, PA-C, CSC-S, CSE, IF, MSCP, HAES

0:47
Louise Emmett, MD, PhD, MBChB, FRACP, on the potential role of 225Ac-PSMA-617 earlier in mCRPC
25 days ago

0:35
Lucia Nappi, MD, on the future for miR371 in testicular cancer
a month ago
by
Lucia Nappi, MD, PhD, FRCPC

0:42
Joshua Lang, MD, MS, highlights emerging biomarker strategies in GU oncology
a month ago
by
Joshua Lang, MD, MS

1:24
Integrating immunotherapy into newly diagnosed MIBC
a month ago
by
María Natalia Gandur Quiroga, MD, MSc

0:33
Kari A.O. Tikkinen, MD, PhD, discusses tranexamic acid in urology
a month ago
by
Kari A.O. Tikkinen, MD, PhD

1:38
Nicole L. Miller, MD, FACS, on advances in evaluating and treating LUTS
a month ago
by
Nicole L. Miller, MD, FACS

0:32
Catherine A. Matthews, MD, FACS, shares takeaways from the INTIBIA Pivotal Trial
a month ago
by
Catherine A. Matthews, MD, FACOG, FACS, FPMRS

0:22
Michael S. Cookson, MD, on darolutamide’s safety profile
a month ago
by
Michael S. Cookson, MD, MMHC, FACS

0:41
Jonathan D. Harper, MD, on increasing fluid intake to prevent recurrent stones
a month ago
by
Jonathan D. Harper, MD

0:57
Nima Almassi, MD, on shared decision-making around bladder-preserving treatment options
a month ago
by
Nima Almassi, MD

0:49
Kathryn H. Gessner, MD, PhD, on the most exciting current developments in bladder cancer
a month ago
by
Kate Gessner, MD, PhD

0:18
Joshua J. Meeks, MD, PhD, on the need for recombinant BCG
a month ago
by
Joshua J. Meeks, MD, PhD

0:39
Nicole L. Miller, MD, FACS, on what she tells patients after BPH treatment failure
a month ago
by
Nicole L. Miller, MD, FACS

0:30
Michael S. Cookson, MD, on what ARASEC adds to the treatment intensification discussion
a month ago
by
Michael S. Cookson, MD, MMHC, FACS
Advertisement
Advertisement
Trending on Urology Times
1
ARASEC: Clinical Implications and the Role of Multidisciplinary Care
2
FDA grants tentative approval to generic enzalutamide tablets
3
2026 AUA/SUO Advanced Prostate Cancer Guideline: Key updates and clinical FAQs
4
Fred Saad, MD, highlights PSA end points from the phase 3 PSMAddition trial
5
